Articles From: Immunomedics Announces Outcome of 2014 Annual Meeting of Stockholders to Imperial Holdings, Inc. Announces Third Quarter 2014 Results


MORRIS PLAINS, N.J., Dec.
Sign-up for Immunomedics Announces Outcome of 2014 Annual Meeting of Stockholders investment picks
MORRIS PLAINS, N.J., Oct.
Sign-up for Immunomedics Announces Presentations at the 2014 European Association of Nuclear Medicine Congress investment picks
MORRIS PLAINS, N.J., Nov.
Sign-up for Immunomedics Announces Six Presentations on Epratuzumab in Lupus at Leading Rheumatology Meeting investment picks
BARCELONA, Spain, Nov.
Sign-up for Immunomedics Presents Clinical Data on Novel Antibody-Drug Conjugates for Solid Cancer Therapy investment picks
-- T-cell Killing of Human Gastric and Pancreatic Cancer Cell Lines Enhanced With Interferon-α --
Sign-up for Immunomedics Publishes Results on Immunotherapy of Solid Cancers Mediated by a Novel Bispecific Antibody investment picks
MORRIS PLAINS, N.J., Nov.
Sign-up for Immunomedics Receives Third Edison Patent Award From Research & Development Council of New Jersey investment picks
MORRIS PLAINS, N.J., Dec.
Sign-up for Immunomedics to Present at 25th Annual Oppenheimer Healthcare Conference investment picks
2014/10/21
Immunotech Laboratories, Inc. (OTC PINK: IMMB) (“Immunotech” or the “Company”) and wholly-owned subsidiary Immunotech Laboratories, BG (IMMB-BG) today announced that they have successfully completed negotiations with Uldic Investment Pvt.
Sign-up for Immunotech Laboratories, Inc. Enters into Agreement to Market Potential Ebola Virus Disease (“EVD”) Treatment and Implement Strategy for Company's ITV-1 Infectious Diseases Treatment in Africa investment picks
2014/10/9
Immunotech Laboratories, Inc. (OTCMARKETS: IMMB) Immunotech Laboratories, Inc.(the “Company”) and Immunotech Laboratories, BG (IMMB-BG”) the Company announced today that they have entered into negotiations with Uldic Investment Pvt.
Sign-up for Immunotech Laboratories, Inc. Enters Into Negotiations With Uldic Investment Pvt. Ltd. For Market Development investment picks
2014/10/7
Immunotech Laboratories, Inc. (OTCMARKETS: IMMB) and Immunotech Laboratories, BG.
Sign-up for Immunotech Laboratories, Inc. Updates Progress on Negotiations for Phase III Testing on its Treatments for HIV/AIDS and Hepatitis C Viruses in Macedonia and Serbia investment picks
2014/10/15
http://media.marketwire.com/attachments/201109/23388_ecologo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1151596&ProfileId=051205&sourceType=1 LOS ANGELES, CA --
Sign-up for Impact of Large Restaurant Industry Follow-On Orders for Eco-Safe Systems investment picks
Study shows greatest cost linked to people with depression, COPD, coronary artery disease and dementia ABBOTT PARK, Ill., Dec.
Sign-up for Impact of Malnutrition in U.S. at $157 Billion Annually investment picks
2014/11/12
A new study from Expedia® Media Solutions, the advertising sales division of Expedia, Inc., analyzes the importance of multiplatform devices in online travel content consumption and provides an in-depth look at device usage and trends, research and booking habits, and unique behaviors across audience segments.
Sign-up for Impact of Multiscreen Devices on Travel Content Engagement and Audience Behavior Revealed in New Study from Expedia Media Solutions and comScore investment picks
-- Optimizes resources by leveraging shared-services -- --
Sign-up for Impax Announces R&D Reorganization Designed to Yield Process Improvements and Efficiencies investment picks
-- Acquisitions includes operating subsidiaries CorePharma, LLC and Amedra Pharmaceuticals LLC -- --
Sign-up for Impax To Acquire Tower Holdings, Inc. And Lineage Therapeutics Inc. investment picks
-- Third Quarter 2014 Adjusted Diluted EPS Increased to $0.33; GAAP Diluted EPS Increased to $0.22 -- --
Sign-up for Impax's Third Quarter 2014 Revenues Increased 19% to $158 Million investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0973248001&sourceType=1 http://media3.marketwire.com/logos/20121102-iiinew.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Imperial Announces Normal Course Issuer Bid investment picks
Imperial Holdings, Inc. (NYSE: IFT) announced today that its Board of Directors has adopted a by-law that requires a shareholder, before filing a lawsuit against the company, its board of directors or its officers, to obtain consents of shareholders beneficially owning at least three (3) percent of Imperial’s common shares.
Sign-up for Imperial Holdings Adopts By-law Regarding Claims by Shareholders investment picks
Imperial Holdings, Inc. (NYSE: IFT) ("Imperial"), a specialty finance company with a focus on providing liquidity solutions to owners of illiquid financial assets, announced today it has entered into an agreement to sell up to $100 million in senior secured notes to an affiliate of Indaba Capital Management, L.P. (“Indaba”), one of Imperial’s largest shareholders.
Sign-up for Imperial Holdings Closes Facility for up to $100 Million with Indaba Capital Management investment picks
Imperial Holdings, Inc. (NYSE: IFT), a specialty finance company with a focus on providing liquidity solutions to owners of illiquid financial assets, has become a member of the European Life Settlement Association (ELSA), an organization dedicated to setting standards and promoting best practices for the European life settlement industry.
Sign-up for Imperial Holdings Joins European Life Settlement Association investment picks
Imperial Holdings, Inc. (NYSE: IFT) ("Imperial"), a specialty finance company with a focus on providing liquidity solutions to owners of illiquid financial assets, announced today it has signed and moved into an 11,000 square foot lease negotiated by CBRE at MetLife’s The Plaza in Boca Raton.
Sign-up for Imperial Holdings Moves into New Corporate Offices investment picks
Imperial Holdings, Inc. (NYSE: IFT) ("Imperial" or the "Company"), a specialty finance company with a focus on providing liquidity solutions to owners of illiquid financial assets, announced today its financial results for the three and nine month periods ended September 30, 2014.
Sign-up for Imperial Holdings, Inc. Announces Third Quarter 2014 Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Immunomedics Announces Outcome of 2014 Annual Meeting of Stockholders to Imperial Holdings, Inc. Announces Third Quarter 2014 Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent